Members of a federal commission charged with studying COVID-19 in nursing homes have been named.
Jay Schnitzer
As of yesterday, CDC’s official tally of COVID-19 deaths was 119,055. The estimates vary quite a bit, but there’s no question that a sizable proportion of those deaths have occurred among residents of nursing homes and other long-term facilities. As of June 18, the Kaiser Family Foundation’s count was 50,185 in 41 states. In early June, preliminary data from CMS showed 29,457 deaths in nursing home from COVID-19.
CMS and the CDC have issued COVID-19 guidelines for nursing homes. But the way that COVID-19 has played out in the nation's nursing homes is a complex situation, often with human suffering attached. A story in today's New York Times reports that some nursing homes have cleared out residents who don't have COVID-19 because the reimbursment rate for COVID-19 is higher. "With nursing homes not allowing visitors, there is less outside scrutiny of their practices," reports the newspaper. "Fifteen state-funded ombudsmaen said in intereviews tht some homes appear to be taking advantage of that void to evict vulnerable residents."
In late April, CMS announced that it would be setting up an independent Coronavirus Commission for Safety and Quality in Nursing Homes to examine COVID-19-related issues in depth, including identification of best practices for rapid identification and mitigation of transmission and for care delivery. The MITRE Corporation, a federal contractor and research organization with offices in Bedford, Massachusetts, and McLean, Virginia, was hired to set up and run the commission.
Related: In Harm's Way: Nursing Homes in the COVID-19 Pandemic
Last week, CMS and MITRE announced that it had picked the 25 members of the commission out of a pool of 800 applicants. Jay Schnitzer, Ph.D., M.D., MITRE’s chief technology and medical officer, will serve as the commissioner’s moderator.
Here is a list of the 25 members of the commission:
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with Ceci Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
The Departments of Health and Human Services (HHS), Labor, and the Treasury, released final rules on short-term, limited-duration insurance (STLDI) and independent, non-coordinated excepted benefits coverage, addressing issues related to the low-quality insurance, or "junk insurance" plans.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and Ceci Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 28th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
Muthiah “Muthu” Vaduganathan Discusses the Role of SGLT2 Inhibitors in Heart Failure Treatment
March 27th 2024Editors of Managed Healthcare Executive spoke with Muthiah “Muthu” Vaduganathan MD, MPH, consultant cardiologist at Brigham and Women's Hospital and a member of faculty at Harvard Medical School, about the evolving treatment landscape for heart failure, emphasizing the use of SGLT2 inhibitors alongside other foundational therapies.
Read More